Financial Statements

SUMMARY STATEMENT OF FINANCIAL POSITION  
as atMarch 31, 2018 (000's)March 31, 2017 (000's)
ASSETS
Current Assets11,322 5,880
Restricted Assets1019
Capital Assets135,550
64,012
Total146,882
69,911
LIABILITIES, DEFERRED CONTRIBUTIONS AND NET ASSETS
Current Liabilities16,692
12,270
Long term liabilities and deferred contributions117,548
46,342
Unrestricted Net Assets12,632
11,280
Restricted Net Assets1019
Total146,882
69.911

 

SUMMARY STATEMENT OF OPERATIONS  
Year EndedMarch 31, 2018 (000's)March 31, 2017 (000's)
REVENUES
Ministry of Health and Long-Term Care and South West Local Health Integration Network78,623
74,288
Other20,154
18,857
Total98,777
93,145
EXPENSES
Salaries and benefits56,184
54,182
Other40,278
37,992
Total96,462
92,174
Excess of revenues over expenses from operations2,315
971
Other revenue (expenses)(972)
(1,610)
Excess of revenues over expenses1,343
(639)

 

SUMMARY STATEMENT OF CASH FLOWS  
Year EndedMarch 31, 2018 (000's)March 31, 2017 (000's)
CASH PROVIDED BY (USED IN):
Operating Activities4,817
3,225
Financing Activities76,414
2,107
Investing Activities(77,359)
(7,360)
Net decrease in cash3,872
(2,028)
Cash, beginning of year$1,490
$3,518
Cash, end of year$5,362
$1,490

 

Basis of Presentation

The information contained in the summary financial statements is in agreement with the related information in the complete audited financial statements. The summary financial statements contain major subtotals and totals from the complete audited financial statements.

Total Revenue by Type

  • MOHLTC and SW-LHIN
    79.60% ($78,622,804)
  • Patient
    12.05% ($11,898,274)
  • Non-Patient
    6.80%($6,713,934)
  • Preferred Accomodation
    0.64% ($632,157)
  • Amortization of Deferred Captial Contributions
    0.92% ($909,356)

STEGH Operating Expenses

  • Compensation
    58.2% ($56,183,933)
  • General Supplies
    15.9% ($15,368,514)
  • Medical Staff Remuneration
    14.8% ($14,272,256)
  • Medical and Surgical Supplies
    4.6% ($4,465,998)
  • Amortization of Equipment
    2.6% ($2,512,445)
  • Drugs
    3.7% ($3,535,493)
  • Short Term Interest
    0% ($27,261)
  • Bad Debts
    0.1% ($95,833)